MyFinsight
Home
About
Contact
biib: the income statement
Download
Download image
Royalty
$9.7M
(-65.72%↓ Y/Y)
Contract Manufacturing
And Other Revenue
$141.5M
(-36.23%↓ Y/Y)
Other revenues from
anti-cd20 therapeutic...
$6.5M
(41.30%↑ Y/Y)
Biogen's share of pre-tax
profits in the u.s. for...
$101M
(6.54%↑ Y/Y)
Royalty Attributed To
OCREVUS
$386.4M
(11.42%↑ Y/Y)
Non Us
$911.6M
(-4.68%↓ Y/Y)
US
$935.3M
(15.04%↑ Y/Y)
Product And Service
Other
$151.2M
(-39.57%↓ Y/Y)
LEQEMBICollaboration
$42.7M
Revenuesfromanticd20therapeuticprograms
$493.9M
(10.69%↑ Y/Y)
Product
$1,846.9M
(4.38%↑ Y/Y)
Total revenue
$2,534.7M
(2.79%↑ Y/Y)
Income before income
tax (benefit)...
$557.3M
(23.57%↑ Y/Y)
Total cost and expense
$1,977.4M
(-1.86%↓ Y/Y)
Net income
attributable to biogen inc
$466.5M
(20.08%↑ Y/Y)
Income tax (benefit)
expense
$90.8M
(45.28%↑ Y/Y)
Other (income)
expense, net
-$34.1M
(-130.41%↓ Y/Y)
Restructuring charges
$7.4M
(8.82%↑ Y/Y)
Business combination,
contingent consideration,...
$5.6M
(-76.47%↓ Y/Y)
Collaboration profit
sharing/(loss reimbursement)
$87.2M
(25.83%↑ Y/Y)
Amortization and impairment
of acquired...
$135.7M
(4.14%↑ Y/Y)
Selling, general and
administrative
$594.8M
(1.09%↑ Y/Y)
Acquired in-process
research and...
$2.1M
Research and development
$436.1M
(-19.64%↓ Y/Y)
Cost of sales,
excluding amortization...
$674.4M
(5.59%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Biogen-svg
BIOGEN INC. (BIIB)
Biogen-svg
BIOGEN INC. (BIIB)